mAbs Treatment: Minimizing Hurdles and Why Accessibility Matters

Last month we wrote about monoclonal antibody treatments (mAbs) and the critical role they play in preventing hospitalizations amid the constantly shifting COVID-19 landscape of variants and hot spots. Most recently, we’re learning where mAbs are most effective given rising rates of variants in particular regions.


Sign up for updates and alerts